Journal of Nuclear Cardiology

, Volume 26, Issue 1, pp 222–226 | Cite as

Patient page-sarcoidosis imaging

  • John P. Bois
  • Panithaya ChareonthaitaweeEmail author
Review Article


Optimizing our imaging capabilities for patients with cardiac sarcoidosis is critical as it has diagnostic, prognostic, and therapeutic implications. 18FDG PET/CT has the highest sensitivity for the detection of CS but requires specific dietary preparation that is difficult for patients to follow which may lead to ineffective suppression of physiologic 18FDG uptake. This may result in inconclusive scan results in up to 30% of patients undergoing 18FDG PET/CT imaging for CS. Therefore, it is imperative that we relay to our patients the importance of dietary preparation for CS PET imaging and then provide simple, easy to follow instructions for them. The current patient protocol is designed to achieve these two objectives.


Cardiac sarcoid PET Patient protocol 



Cardiac sarcoidosis


F-18 fluorodeoxyglucose


Positron emission tomography



The authors have nothing to disclose.

Supplementary material

12350_2017_1100_MOESM1_ESM.pptx (209 kb)
Supplementary material 1 (PPTX 208 kb)


  1. 1.
    Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017. doi: 10.2967/jnumed.117.196287.Google Scholar
  2. 2.
    Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.CrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2017

Authors and Affiliations

  1. 1.Department of Cardiovascular MedicineMayo ClinicRochesterUSA

Personalised recommendations